» Articles » PMID: 26551716

The Blood-brain Barrier Endothelium: a Target for Pro-inflammatory Cytokines

Overview
Specialty Biochemistry
Date 2015 Nov 10
PMID 26551716
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

An intact functioning blood-brain barrier (BBB) is fundamental to proper homoeostatic maintenance and perfusion of the central nervous system (CNS). Inflammatory damage to the unique microvascular endothelial cell monolayer that constitutes the luminal BBB surface, leading to elevated capillary permeability, has been linked to various neurological disorders ranging from ischaemic stroke and traumatic brain injury, to neurodegenerative disease and CNS infections. Moreover, the neuroinflammatory cascade that typically accompanies BBB failure in these circumstances has been strongly linked to elevated levels of pro-inflammatory cytokines such as tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6). This mini review will examine our current knowledge of how cytokines may dysregulate the interendothelial paracellular pathway leading to elevated BBB permeability. The mechanistic role of nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase)-induced oxidative stress in these events will also be addressed.

Citing Articles

Polymerase delta-interacting protein 2 mediates brain vascular permeability by regulating ROS-mediated ZO-1 phosphorylation and localization at the interendothelial border.

Wang K, Qu H, Hu R, Lassegue B, Eaton D, Song C Cell Commun Signal. 2025; 23(1):9.

PMID: 39773189 PMC: 11705911. DOI: 10.1186/s12964-024-01982-3.


Cerebrospinal fluid proteomics reveals the innate immunity and blood-brain barrier dysregulation in a patient with multidrug-resistant ventriculitis treated with intrathecal and intravenous polymyxin B.

Li M, Liu D, Bergen P, Liang S, Chen J, Kho Z Heliyon. 2025; 10(24):e40893.

PMID: 39759273 PMC: 11699078. DOI: 10.1016/j.heliyon.2024.e40893.


Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.

Digiovanni S, Lorenzati M, Bianciotto O, Godel M, Fontana S, Akman M Fluids Barriers CNS. 2024; 21(1):89.

PMID: 39487455 PMC: 11529439. DOI: 10.1186/s12987-024-00590-0.


A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood-Brain Barrier Crossing Therapeutic Strategies.

Chim S, Howell K, Kokkosis A, Zambrowicz B, Karalis K, Pavlopoulos E Pharmaceutics. 2024; 16(10).

PMID: 39458643 PMC: 11510380. DOI: 10.3390/pharmaceutics16101314.


MMP-3 Knockout Induces Global Transcriptional Changes and Reduces Cerebral Infarction in Both Male and Female Models of Ischemic Stroke.

Hamblin M, Boese A, Murad R, Lee J Int J Mol Sci. 2024; 25(13).

PMID: 39000490 PMC: 11242542. DOI: 10.3390/ijms25137383.